MCID: SCR001
MIFTS: 30

Secretory Meningioma

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Secretory Meningioma

MalaCards integrated aliases for Secretory Meningioma:

Name: Secretory Meningioma 12 55 15 73
Meningioma 73

Classifications:



External Ids:

Disease Ontology 12 DOID:4588
MeSH 44 D008579
NCIt 50 C4718
SNOMED-CT 68 19453003

Summaries for Secretory Meningioma

MalaCards based summary : Secretory Meningioma, also known as meningioma, is related to malignant peritoneal mesothelioma and papillary tumor of the pineal region. An important gene associated with Secretory Meningioma is MUC1 (Mucin 1, Cell Surface Associated), and among its related pathways/superpathways are Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers and Cytoskeletal Signaling. The drugs Thrombin and Coagulants have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and liver.

Related Diseases for Secretory Meningioma

Diseases related to Secretory Meningioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 125)
# Related Disease Score Top Affiliating Genes
1 malignant peritoneal mesothelioma 10.1 MUC1 VIM
2 papillary tumor of the pineal region 10.1 MUC1 VIM
3 syringocystadenoma papilliferum 10.1 MUC1 VIM
4 ossifying fibromyxoid tumor 10.1 MUC1 VIM
5 fibrous meningioma 10.1 MUC1 VIM
6 chordoid meningioma 10.1 MUC1 VIM
7 clear cell ependymoma 10.1 MUC1 VIM
8 ependymoma 10.1 MUC1 VIM
9 eccrine porocarcinoma 10.1 MUC1 VIM
10 endometrial mucinous adenocarcinoma 10.1 MUC1 VIM
11 biphasic synovial sarcoma 10.1 MUC1 VIM
12 adenofibroma 10.1 MUC1 VIM
13 clear cell meningioma 10.1 MUC1 VIM
14 myxopapillary ependymoma 10.1 MUC1 VIM
15 melanotic neuroectodermal tumor 10.1 MUC1 VIM
16 syringoma 10.1 MUC1 VIM
17 pleomorphic liposarcoma 10.1 MUC1 VIM
18 desmoplastic small round cell tumor 10.1 MUC1 VIM
19 perivascular epithelioid cell tumor 10.1 MUC1 VIM
20 anaplastic ependymoma 10.1 MUC1 VIM
21 reticulum cell sarcoma 10.1 MUC1 VIM
22 sertoli cell tumor 10.1 MUC1 VIM
23 mesenchymal chondrosarcoma 10.1 MUC1 VIM
24 extraskeletal ewing sarcoma 10.1 MUC1 VIM
25 perineurioma 10.1 MUC1 VIM
26 chondroid chordoma 10.1 MUC1 VIM
27 dendritic cell tumor 10.0 MUC1 VIM
28 cerebral primitive neuroectodermal tumor 10.0 MUC1 VIM
29 polymorphous low-grade adenocarcinoma 10.0 MUC1 VIM
30 hemangiopericytoma, malignant 10.0 MUC1 VIM
31 malignant fibroxanthoma 10.0 MUC1 VIM
32 osteofibrous dysplasia 10.0 MUC1 VIM
33 cystadenocarcinoma 10.0 KRT7 MUC1
34 fasciitis 10.0 MUC1 VIM
35 solid adenocarcinoma with mucin production 10.0 KRT7 MUC1
36 endosalpingiosis 10.0 KRT7 MUC1
37 bile duct mucoepidermoid carcinoma 10.0 KRT7 MUC1
38 rhabdoid tumor predisposition syndrome 1 10.0 MUC1 VIM
39 mucoepidermoid carcinoma 10.0 KRT7 MUC1
40 middle ear adenoma 10.0 KRT7 MUC1
41 cystadenoma 10.0 KRT7 MUC1
42 optic nerve glioma 10.0 MUC1 VIM
43 mucinous adenocarcinoma 10.0 KRT7 MUC1
44 meningioma, radiation-induced 10.0 MUC1 VIM
45 bile duct cystadenocarcinoma 10.0 KRT7 MUC1
46 adenomyoma 10.0 KRT7 MUC1
47 mucinous ovarian cystadenoma 10.0 KRT7 MUC1
48 paget disease, extramammary 10.0 KRT7 MUC1
49 mucinous bronchioloalveolar adenocarcinoma 10.0 KRT7 MUC1
50 well-differentiated liposarcoma 10.0 KRT7 MUC1

Graphical network of the top 20 diseases related to Secretory Meningioma:



Diseases related to Secretory Meningioma

Symptoms & Phenotypes for Secretory Meningioma

Drugs & Therapeutics for Secretory Meningioma

Drugs for Secretory Meningioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 265)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Thrombin Approved, Investigational Phase 4
2 Coagulants Phase 4,Phase 3
3 Hemostatics Phase 4,Phase 3
4 Fibrin Tissue Adhesive Phase 4
5
Tranexamic Acid Approved Phase 3 1197-18-8 5526
6
Progesterone Approved, Vet_approved Phase 3 57-83-0 5994
7
Mifepristone Approved, Investigational Phase 3 84371-65-3 55245
8
Donepezil Approved Phase 3,Phase 2,Early Phase 1 120014-06-4 3152
9
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
10
Cisplatin Approved Phase 3,Phase 2 15663-27-1 2767 441203 84093
11
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 1 1177-87-3
12
Ondansetron Approved Phase 3 99614-02-5 4595
13
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
14
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 1 50-02-2 5743
15
Cisatracurium Approved Phase 3 96946-41-7
16
Sevoflurane Approved, Vet_approved Phase 3 28523-86-6 5206
17
Propofol Approved, Investigational, Vet_approved Phase 3 2078-54-8 4943
18
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 3 7487-88-9 24083
19
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
20
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
21
Histamine Approved, Investigational Phase 3 51-45-6, 75614-87-8 774
22
Cyproheptadine Approved Phase 3 129-03-3 2913
23 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
24 Antifibrinolytic Agents Phase 3
25 Liver Extracts Phase 3,Phase 1,Phase 2
26 Gastrointestinal Agents Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
27 Dermatologic Agents Phase 3,Phase 2,Phase 1
28 Contraceptives, Oral Phase 3
29 Contraceptive Agents Phase 3
30 glucocorticoids Phase 3,Phase 1
31 Progestins Phase 3
32 Contraceptives, Postcoital Phase 3
33 Hormone Antagonists Phase 3,Phase 2,Phase 1,Not Applicable
34 Hormones Phase 3,Phase 2,Phase 1,Not Applicable
35 Luteolytic Agents Phase 3
36 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1,Not Applicable
37 Neurotransmitter Agents Phase 3,Phase 2,Phase 1,Early Phase 1
38 Nootropic Agents Phase 3,Phase 2,Early Phase 1
39 Cholinergic Agents Phase 3,Phase 2,Early Phase 1
40 Cholinesterase Inhibitors Phase 3,Phase 2,Early Phase 1
41 Cola Phase 3,Phase 1
42 Central Nervous System Depressants Phase 3,Phase 2,Phase 1,Not Applicable
43 Adjuvants, Anesthesia Phase 3
44 Anesthetics, Intravenous Phase 3
45 Analgesics, Opioid Phase 3
46 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1,Not Applicable
47 Anesthetics, General Phase 3
48 Analgesics Phase 3,Phase 2,Phase 1
49 Narcotics Phase 3
50 Anesthetics Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 193)
# Name Status NCT ID Phase Drugs
1 Cavernous Sinus Dissection and Bleeding in Meningiomas Unknown status NCT02863484 Phase 4
2 Phase IV Bioseal Study in Brain Tumor Surgery Completed NCT02034799 Phase 4
3 Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial. Not yet recruiting NCT03190122 Phase 4
4 SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors Unknown status NCT00517959 Phase 3
5 Efficacy of Tranexamic Acid in Brain Tumor Resections Unknown status NCT01655927 Phase 3 Tranexamic Acid;Placebo: Saline
6 S9005 Mifepristone in Meningioma Completed NCT03015701 Phase 3 Mifepristone
7 Proton/Photon Rt - Benign Meningiomas(P92-13) Completed NCT02947984 Phase 3
8 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
9 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
10 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
11 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery Recruiting NCT03180268 Phase 3
12 Magnesium and Intraoperative Blood Loss in Meningioma Surgery Not yet recruiting NCT03558516 Phase 3 Magnesium group;Normal saline group
13 Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery Terminated NCT00104936 Phase 3
14 Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors Terminated NCT00031798 Phase 3 methylphenidate hydrochloride
15 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
16 Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas Unknown status NCT02333565 Phase 2 Everolimus;Octreotide
17 Proton Radiation For Meningiomas and Hemangiopericytomas Unknown status NCT01117844 Phase 1, Phase 2
18 Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma Unknown status NCT00904735 Phase 2 hydroxyurea;imatinib mesylate
19 Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma Unknown status NCT00006119 Phase 2 hydroxyurea
20 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
21 Monthly SOM230C for Recurrent or Progressive Meningioma Completed NCT00859040 Phase 2 SOM230C
22 S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma Completed NCT00003590 Phase 2 hydroxyurea
23 Combination of Hydroxyurea and Verapamil for Refractory Meningiomas Completed NCT00706810 Phase 2 Hydroxyurea;Verapamil
24 Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas Completed NCT00002965 Phase 2
25 Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma Completed NCT00626730 Phase 2
26 Imatinib Mesylate in Treating Patients With Recurrent Meningioma Completed NCT00045734 Phase 2 imatinib mesylate
27 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Completed NCT00589784 Phase 2 Sunitinib
28 Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Completed NCT00348790 Phase 2 vatalanib
29 Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma Completed NCT00354913 Phase 2 hydroxyurea;imatinib mesylate
30 Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma Completed NCT00010049 Phase 1, Phase 2 imatinib mesylate
31 Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma Completed NCT00045110 Phase 1, Phase 2 erlotinib hydrochloride
32 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
33 Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors Completed NCT00025675 Phase 2 gefitinib
34 Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 Completed NCT01419639 Phase 2 Everolimus (RAD001) , Afinitor®
35 Theranostics: 68GaDOTATOC and 90YDOTATOC Completed NCT02441088 Phase 2 90Y-DOTA-tyr3-Octreotide;Aminosyn II
36 Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) Completed NCT01207687 Phase 2
37 Irinotecan in Treating Children With Refractory Solid Tumors Completed NCT00004078 Phase 2 irinotecan hydrochloride
38 Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy Completed NCT00463203 Phase 2 Bevacizumab;Irinotecan
39 Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors Completed NCT01032200 Phase 2 Armodafinil
40 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors Completed NCT00629889 Phase 2 levetiracetam;pregabalin
41 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00006102 Phase 2 becatecarin
42 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Completed NCT00005955 Phase 2 temozolomide
43 SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy Completed NCT00004868 Phase 1, Phase 2 semaxanib
44 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2 donepezil hydrochloride
45 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors Completed NCT00003461 Phase 1, Phase 2
46 Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer Completed NCT00014573 Phase 2 carmustine;cisplatin;cyclophosphamide;paclitaxel
47 Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Completed NCT00973739 Phase 2 Lapatinib
48 Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas Recruiting NCT03071874 Phase 2 AZD2014
49 Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma Recruiting NCT03279692 Phase 2 Pembrolizumab
50 A Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma Recruiting NCT02648997 Phase 2 Nivolumab

Search NIH Clinical Center for Secretory Meningioma

Genetic Tests for Secretory Meningioma

Anatomical Context for Secretory Meningioma

MalaCards organs/tissues related to Secretory Meningioma:

41
Brain, Bone, Liver, Pituitary, Lung, Kidney, Thymus

Publications for Secretory Meningioma

Articles related to Secretory Meningioma:

(show top 50) (show all 782)
# Title Authors Year
1
In vitro assessment of radiobiology of meningioma: A pilot study. ( 30408557 )
2019
2
Uptake and Tracer Kinetic of O-(2-(18)F-fluoroethyl)-L-Tyrosine in Meningioma. ( 30540599 )
2019
3
Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma. ( 30546952 )
2019
4
Pearls & Oy-sters: Persistent elevation of serum carcinoembryonic antigen in secretory meningioma. ( 29438031 )
2018
5
Contiguous Metastasis of Pulmonary Adenocarcinoma to Meningioma. ( 30321884 )
2018
6
Value of Internal Carotid Artery Stenosis in the Differential Diagnosis between Invasive Pituitary Adenoma and Invasive Meningioma. ( 29532781 )
2018
7
Preoperative Prediction of Solitary Fibrous Tumor/Hemangiopericytoma and Angiomatous Meningioma Using Magnetic Resonance Imaging Texture Analysis. ( 30240864 )
2018
8
A rare case of diffuse intracranial aspergillosis masquerading as skull base meningioma in an immunocompetent patient. ( 30232959 )
2018
9
Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age. ( 30099534 )
2018
10
In Reply to ""Wounded Meningioma Syndrome": Postoperative Exacerbation of Brain Edema in Brain-Invasive Meningioma". ( 29958376 )
2018
11
Giant Bilateral Calvarial Hyperostosis Secondary to Small Unilateral Frontal Meningioma. ( 30271067 )
2018
12
In Response to the Letter to the Editor Regarding "Optic Nerve Meningioma Mimicking Cavernous Hemangioma". ( 29288857 )
2018
13
A giant solid cavernous hemangioma mimicking sphenoid wing meningioma in an adolescent: A case report. ( 30383694 )
2018
14
Microsurgical Resection of Cavernous Sinus Meningioma: 2-Dimensional Operative Video. ( 29514273 )
2018
15
Gamma Knife stereotactic radiosurgery for cavernous sinus meningioma: long-term follow-up in 200 patients. ( 30028261 )
2018
16
Radiosurgery and fractionated radiotherapy for cavernous sinus meningioma: a systematic review and meta-analysis. ( 30393820 )
2018
17
Suboccipital Lateral Approach for Resection of Cerebellopontine Angle Meningioma: Operative Video and Technical Nuances. ( 30456039 )
2018
18
Gross Total Resection of Large Cerebellopontine Angle Meningioma with a Supratentorial Extension via Retrosigmoid Approach with Suprameatal Drilling and Tentorial Sectioning. ( 30456040 )
2018
19
Retrosigmoid Approach for Resection of Cerebellopontine Angle Meningioma. ( 30456043 )
2018
20
Participation restrictions in patients after surgery for cerebral meningioma. ( 30264851 )
2018
21
Foramen Magnum Chordoid Meningioma in a 22-Year-old Female. ( 30283559 )
2018
22
Spinal Clear Cell Meningioma: Clinical Study with Long-Term Follow-Up in 12 Patients. ( 30342264 )
2018
23
Intracranial clear cell meningioma: Clinical study with long-term follow-up in 24 patients. ( 30384120 )
2018
24
Two novel cases of spinal clear cell meningioma with vertebra involvement. ( 30545721 )
2018
25
Management of concomitant metabolic encephalopathy and meningioma with vasogenic edema and impending herniation. ( 29492325 )
2018
26
Isolated Tuberculoma Mimicking Foramen Magnum Meningioma in the Absence of Primary Tuberculosis: A Case Report. ( 30145853 )
2018
27
Collision Tumor of Glioblastoma and Meningioma: Case Report and Literature Review. ( 29890277 )
2018
28
Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma. ( 30052597 )
2018
29
Guillain-Barre Syndrome Complicated on Postoperation on Renal Carcinoma and Meningioma. ( 29692389 )
2018
30
Severe headache in a patient with meningioma showing extensive dural tail correlates with IgG4-positive plasma cells and eosinophils: A case report and review of literature. ( 30386672 )
2018
31
Pre- and postoperative headache in patients with meningioma. ( 30089403 )
2018
32
Central nervous system histoplasmosis mimicking tentorium meningioma. ( 30304288 )
2018
33
Spinal canal meningioma mimicking posterior fossa ischemia on CT perfusion: A CT perfusion pitfall. ( 30228845 )
2018
34
68Ga-DOTATATE PET/CT Reveals Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma in a Case of Suspected Sphenoid Wing Meningioma. ( 29401153 )
2018
35
Paraneoplastic Nephrotic Syndrome in a Patient with Planum Sphenoidale Meningioma. ( 30283568 )
2018
36
Regression of Giant Olfactory Groove Meningioma and Complete Visual Acuity Recovery after Discontinuation of Cyproterone Acetate. ( 30090195 )
2018
37
Minimally Invasive Interhemispheric Approach for Giant Olfactory Groove Meningioma: Technical Note. ( 30217781 )
2018
38
Olfactory groove meningioma masquerading as psychiatric disturbances. ( 30405268 )
2018
39
Optic nerve sheath meningioma. ( 30054955 )
2018
40
The Use of 68Ga-DOTATATE PET/CT in the Non-invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report. ( 30386741 )
2018
41
Otitis Media with Effusion Revealing Underlying Meningioma. ( 29764792 )
2018
42
Mixture Model Segmentation System for Parasagittal Meningioma brain Tumor Classification based on Hybrid Feature Vector. ( 30392052 )
2018
43
Resection of Petroclival Meningioma Through Retrosigmoid Approach-Concepts and Nuances: 3- Dimensional Operative Video. ( 29444298 )
2018
44
Susceptibility-Weighted Imaging of Deep Venous Congestion in Petroclival Meningioma. ( 30236813 )
2018
45
Resection of a Petroclival Meningioma via the Endoscope-Assisted Retrosigmoid Approach: 2-D Operative Video. ( 30456038 )
2018
46
Preservation of venous drainage in middle fossa during combined transpetrosal approach for petroclival meningioma. ( 30529519 )
2018
47
Pathological laughter as an early and unusual presenting symptom of petroclival meningioma: A case report and review of literature. ( 30554003 )
2018
48
Giant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical Case. ( 29981911 )
2018
49
A Rare Case of Isolated Intracranial Rosai-Dorfman Disease Mimicking Optic Nerve Meningioma: A Case Report and Literature Review. ( 30283562 )
2018
50
Fractionated Gamma Knife Radiosurgery as Initial Treatment for Large Skull Base Meningioma. ( 30022876 )
2018

Variations for Secretory Meningioma

Expression for Secretory Meningioma

Search GEO for disease gene expression data for Secretory Meningioma.

Pathways for Secretory Meningioma

Pathways related to Secretory Meningioma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.38 KLF4 VIM
2 11.29 KRT7 MUC1 VIM
3 11.21 MUC1 VIM
4
Show member pathways
10.99 KRT7 VIM

GO Terms for Secretory Meningioma

Sources for Secretory Meningioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....